Eli Lilly and Co (NYSE:LLY) over-valued by 11%
| Website | https://www.lilly.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2019 |
| Market Cap | $160,160,514,000 |
| Beta | 0.21783 |
| Average Volume | $4,228,215 |
| Last Dividend | 2.96% |
| Price on Jul 31, 2020 | $167.43 |
| Autochartist™ Valuation | $148.33 |
| Conclusion |
11% over-valued |
| Download Report |
